by Georgia State University Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public Domain An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease,...